Can weight loss boost hormone therapy for Fertility-Sparing endometrial cancer treatment?
NCT ID NCT05316467
First seen Jun 05, 2026 · Last updated Jun 14, 2026 · Updated 3 times
Summary
This study looked at whether adding weight management to a hormone drug (megestrol acetate) helps obese patients with early-stage endometrial cancer who want to preserve fertility. Only 8 people enrolled before the study ended early. The goal was to see if the cancer would disappear after 28 weeks of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Obstetrics and Gynecology Hospital, Fudan University
Shanghai, Shanghai Municipality, 200011, China
Conditions
Explore the condition pages connected to this study.